| 000 | 01767 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517153812.0 | ||
| 264 | 0 | _c20180119 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1475-2875 | ||
| 024 | 7 |
_a10.1186/s12936-017-1851-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNambozi, Michael | |
| 245 | 0 | 0 |
_aArtemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria. _h[electronic resource] |
| 260 |
_bMalaria journal _c05 2017 |
||
| 300 |
_a199 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntimalarials _xtherapeutic use |
| 650 | 0 | 4 | _aArtemether, Lumefantrine Drug Combination |
| 650 | 0 | 4 |
_aArtemisinins _xtherapeutic use |
| 650 | 0 | 4 | _aArtesunate |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aEthanolamines _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorenes _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMalaria _xdrug therapy |
| 650 | 0 | 4 |
_aMefloquine _xtherapeutic use |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aQuinolines _xtherapeutic use |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 | _aZambia |
| 700 | 1 | _aKabuya, Jean-Bertin Bukasa | |
| 700 | 1 | _aHachizovu, Sebastian | |
| 700 | 1 | _aMwakazanga, David | |
| 700 | 1 | _aMulenga, Joyce | |
| 700 | 1 | _aKasongo, Webster | |
| 700 | 1 | _aBuyze, Jozefien | |
| 700 | 1 | _aMulenga, Modest | |
| 700 | 1 | _aVan Geertruyden, Jean-Pierre | |
| 700 | 1 | _aD'Alessandro, Umberto | |
| 773 | 0 |
_tMalaria journal _gvol. 16 _gno. 1 _gp. 199 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12936-017-1851-7 _zAvailable from publisher's website |
| 999 |
_c27180663 _d27180663 |
||